4th Quarter - Report
PORTERFIELD, FETTIG & SEARS, LLC for ASTELLAS PHARMA US, INC.
Client
Income
$50,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
HR.1178 and S.1466, Ensuring Equal Access to Treatments Act; HR 2739, Cancer Drug Coverage Parity Act of 2015
Foreign entity interest: Astellas Pharma, Inc. based in Tokyo, Japan and as identified in our Lobbying Registration has an interest as a pharmaceutical company in all of the issues with respect to which Astellas Pharma US has advocated and listed herein.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JEREMY RABINOVITZ | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.